Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aron Goldhirsch

Showing results (11-20 of 283) with videos related to

Pageof 29
Sort By:
Oncology (Williston Park, N.Y.)|May 15, 2010
Adjuvant endocrine therapy in premenopausal women with operable breast cancer: understanding the issuesAron Goldhirsch, Karen N Price
Nature Reviews. Clinical Oncology|September 6, 2012
Breast cancer: Anastrozole and fulvestrant--combination to unlock efficacyAron Goldhirsch, Richard D Gelber
Breast (Edinburgh, Scotland)|November 27, 2004
Life with consequences of breast cancer: pregnancy during and after endocrine therapiesAron Goldhirsch, Richard D Gelber
Breast Cancer Research : BCR|November 11, 2005
Clinical trial update: International Breast Cancer Study GroupKaren N Price, Aron Goldhirsch,
Breast (Edinburgh, Scotland)|November 17, 2009
Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant settingMarco Colleoni, Giuseppe Viale, Aron Goldhirsch
The Lancet. Oncology|September 10, 2002
Overhauling the breast cancer overview: are subsets subversive?Alan Coates, Aron Goldhirsch, Richard Gelber, et al.
Breast (Edinburgh, Scotland)|August 21, 2007
Immunology and breast cancer: therapeutic cancer vaccinesGiuseppe Curigliano, Maria Rescigno, Aron Goldhirsch
Nature Clinical Practice. Oncology|November 3, 2006
Focusing on physical function limitations in elderly women surviving cancer: any opportunity for improvement?Silvia Dellapasqua, Marco Colleoni, Aron Goldhirsch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Hormonal treatment duration in elderly patients: an open questionDiana Crivellari, Aron Goldhirsch, Alan Coates
Oncotarget|August 23, 2018
Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune systemFabio Conforti, Laura Pala, Aron Goldhirsch
Pageof 29

Showing results (11-20 of 283) with videos related to

Sort By:
Pageof 29
Oncology (Williston Park, N.Y.)|May 15, 2010
Adjuvant endocrine therapy in premenopausal women with operable breast cancer: understanding the issuesAron Goldhirsch, Karen N Price
Nature Reviews. Clinical Oncology|September 6, 2012
Breast cancer: Anastrozole and fulvestrant--combination to unlock efficacyAron Goldhirsch, Richard D Gelber
Breast (Edinburgh, Scotland)|November 27, 2004
Life with consequences of breast cancer: pregnancy during and after endocrine therapiesAron Goldhirsch, Richard D Gelber
Breast Cancer Research : BCR|November 11, 2005
Clinical trial update: International Breast Cancer Study GroupKaren N Price, Aron Goldhirsch,
Breast (Edinburgh, Scotland)|November 17, 2009
Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant settingMarco Colleoni, Giuseppe Viale, Aron Goldhirsch
The Lancet. Oncology|September 10, 2002
Overhauling the breast cancer overview: are subsets subversive?Alan Coates, Aron Goldhirsch, Richard Gelber, et al.
Breast (Edinburgh, Scotland)|August 21, 2007
Immunology and breast cancer: therapeutic cancer vaccinesGiuseppe Curigliano, Maria Rescigno, Aron Goldhirsch
Nature Clinical Practice. Oncology|November 3, 2006
Focusing on physical function limitations in elderly women surviving cancer: any opportunity for improvement?Silvia Dellapasqua, Marco Colleoni, Aron Goldhirsch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2004
Hormonal treatment duration in elderly patients: an open questionDiana Crivellari, Aron Goldhirsch, Alan Coates
Oncotarget|August 23, 2018
Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune systemFabio Conforti, Laura Pala, Aron Goldhirsch
Pageof 29